Emergency Medicine Doctors in Marinette, WI Accepting Medicare

8 Emergency Medicine doctors found. Showing 1 - 8

Richard S Stein, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3003 University Dr, Marinette, WI 54143 Phone: 414-290-6720    Fax: 414-290-6755

Jonathan Weseman, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3003 University Dr, Marinette, Marinette, WI 54143 Phone: 715-735-4200

Dr. Bianca Mercedes Asan Borja, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3100 Shore Dr, Marinette, WI 54143 Phone: 715-735-4200    Fax: 865-292-3015

Dr. Aubrey J Hoye, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3003 University Dr, Marinette, WI 54143 Phone: 715-735-4200

James F Reeves, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3003 University Dr, Marinette, WI 54143 Phone: 715-735-4602

Jeffrey A Swift, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3003 University Dr, Marinette, WI 54143 Phone: 715-735-4200    Fax: 715-735-8019

Dr. Kevin Joseph Reid, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3003 University Dr, Marinette, WI 54143 Phone: 715-735-4200

Siarhei Vysotski, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3003 University Dr, Marinette, WI 54143 Phone: 715-735-4200    Fax: 715-735-8019

News Archive

Johns Hopkins develops PapGene test to diagnose ovarian and endometrial cancers

Using cervical fluid obtained during routine Pap tests, scientists at the Johns Hopkins Kimmel Cancer Center have developed a test to detect ovarian and endometrial cancers. In a pilot study, the "PapGene" test, which relies on genomic sequencing of cancer-specific mutations, accurately detected all 24 (100 percent) endometrial cancers and nine of 22 (41 percent) ovarian cancers. Results of the experiments are published in the Jan. 9 issue of the journal Science Translational Medicine.

KemPharm to initiate clinical trials in Canada for lead product candidate KP201

KemPharm, Inc., a clinical-stage specialty pharmaceutical company engaged in the discovery and development of proprietary new molecular entity (NME) prodrugs, announced today that it received a No Objection Letter (NOL) from Health Canada to begin clinical trials in Canada for its lead product candidate KP201 (benzhydrocodone hydrochloride and acetaminophen)

Battlefield blood transfusion protocol improves patient outcomes

Working to save the lives of military personnel suffering massive blood loss in the Afghanistan and Iraq wars, United States military trauma surgeons developed a blood transfusion protocol that is employed in most military and civilian hospitals today.

Nurses start closing hospital beds in protest of staffing levels

The New South Wales Nurses Association warned that it would keep closing-down beds at Royal Prince Alfred hospital in Sydney's inner west and the Wollongong Hospital until a consensus is reached regarding staffing levels. This Tuesday 40 beds were closed at Wollongong protesting to see a one-nurse-to-four-patient ratio introduced. Beds in the pediatric, intensive care and maternity and emergency wards are spared. Some surgical, rehabilitative and aged care beds are closed.

Eliminating ABCB5-expressing cells crucial for successful colorectal cancer treatment

Researchers at Children's Hospital Boston have found a marker called ABCB5 that both tags a small proportion of cells within colorectal cancers and fuels resistance in those cells to standard treatments. The results indicate that eliminating ABCB5-expressing cells is crucial for successful colorectal cancer treatment, while adding to the growing body of evidence for a theory of cancer growth called the cancer stem cell hypothesis.

Read more Medical News

› Verified 4 days ago